DJIA 17,826.30 -279.47 -1.54%
NASDAQ 4,931.82 -75.98 -1.52%
S&P 500 2,081.18 -23.81 -1.13%
market minute promo


company name or ticker

Progenics (PGNX) Shares March Higher, Can It Continue? - Tale of the Tape

Progenics (PGNX) Shares March Higher, Can It Continue? - Tale of the Tape

An Inefficient Stock Market Will Catch Up To Progenics

This Week in Biotech: AbbVie's Five-Leaf Clover and Exelixis' Excellent Results

A long-awaited mega-merger is announced, Exelixis reminds Wall Street that its pipeline is more than a single compound, and Amgen shows flashes of what's coming down its pipeline.

Funds Are Buying These 5 Rallying Stocks Under $5

Progenics-Salix Up on Encouraging Relistor News - Analyst Blog

Progenics Pharmaceuticals, Inc. (PGNX) in Focus: Stock Rises 8.5% - Tale of the Tape

Can Anything Derail Salix Pharmaceuticals?

Expanded labeling for the sub-q form of Relistor could add $100 million in revenue, but doesn't change the business to a large extent

Morning Market Movers

Monday’s Top Biotech Stories: Mylan, Abbott, Shire, Exelixis, Progenics

Mylan, Abbott, Shire, Exelixis, Progenics are the top health care stocks to follow this Monday morning.

Sector Update: Health-Care Stocks Flat Pre-Market; Abbott Adds 1% on Sale of Generics Business to My

Sector Update: Health-Care Stocks Flat Pre-Market; Abbott Adds 1% on Sale of Generics Business to Mylan
See More Articles...